Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Life and expectations post-kidney transplant: a qualitative analysis of patient responses.

Tucker EL, Smith AR, Daskin MS, Schapiro H, Cottrell SM, Gendron ES, Hill-Callahan P, Leichtman AB, Merion RM, Gill SJ, Maass KL.

BMC Nephrol. 2019 May 16;20(1):175. doi: 10.1186/s12882-019-1368-0.

2.

KPDGUI: An interactive application for optimization and management of a virtual kidney paired donation program.

Bray M, Wang W, Rees MA, Song PX, Leichtman AB, Ashby VB, Kalbfleisch JD.

Comput Biol Med. 2019 May;108:345-353. doi: 10.1016/j.compbiomed.2019.03.013. Epub 2019 Mar 16.

PMID:
31054501
3.

Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.

Helmuth ME, Liu Q, Turenne MN, Park JM, Oguntimein M, Dutcher SK, Balkrishnan R, Sharma P, Zee J, Leichtman AB, Smith AR.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):421-430. doi: 10.2215/CJN.10590918. Epub 2019 Feb 28.

PMID:
30819667
4.

Organ Transplantation in Ethiopia.

Ahmed MM, Tedla FM, Leichtman AB, Punch JD.

Transplantation. 2019 Mar;103(3):449-451. doi: 10.1097/TP.0000000000002551. No abstract available.

PMID:
30801423
5.

Comparison of patient and provider goals, expectations, and experiences following kidney transplantation.

Maass KL, Smith AR, Tucker EL, Schapiro H, Cottrell SM, Gendron E, Hill-Callahan P, Gill SJ, Daskin MS, Merion RM, Leichtman AB.

Patient Educ Couns. 2019 May;102(5):990-997. doi: 10.1016/j.pec.2018.12.010. Epub 2018 Dec 13.

PMID:
30591284
6.

A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size.

Ashby VB, Leichtman AB, Rees MA, Song PX, Bray M, Wang W, Kalbfleisch JD.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1148-1160. doi: 10.2215/CJN.09330916. Epub 2017 Jun 8.

7.

HLA Amino Acid Polymorphisms and Kidney Allograft Survival.

Kamoun M, McCullough KP, Maiers M, Fernandez Vina MA, Li H, Teal V, Leichtman AB, Merion RM.

Transplantation. 2017 May;101(5):e170-e177. doi: 10.1097/TP.0000000000001670.

8.

Coagulation status after therapeutic plasma exchange using citrate in kidney transplant recipients.

Yamada C, Pipe SW, Zhao L, Leichtman AB, Samaniego M, Sung RS, Davenport RD.

Transfusion. 2016 Dec;56(12):3073-3080. doi: 10.1111/trf.13803. Epub 2016 Sep 7.

9.

Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation system.

Stegall MD, Stock PG, Andreoni K, Friedewald JJ, Leichtman AB.

Hum Immunol. 2017 Jan;78(1):4-8. doi: 10.1016/j.humimm.2016.08.008. Epub 2016 Aug 21.

PMID:
27554430
10.

We Need to Take the Next Step.

Melcher ML, Roberts JP, Leichtman AB, Roth AE, Rees MA.

Am J Transplant. 2016 Dec;16(12):3581-3582. doi: 10.1111/ajt.14008. Epub 2016 Sep 12. No abstract available.

11.

Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains.

Melcher ML, Roberts JP, Leichtman AB, Roth AE, Rees MA.

Am J Transplant. 2016 May;16(5):1367-70. doi: 10.1111/ajt.13740. Epub 2016 Mar 9.

12.

Planning for Uncertainty and Fallbacks Can Increase the Number of Transplants in a Kidney-Paired Donation Program.

Bray M, Wang W, Song PX, Leichtman AB, Rees MA, Ashby VB, Eikstadt R, Goulding A, Kalbfleisch JD.

Am J Transplant. 2015 Oct;15(10):2636-45. doi: 10.1111/ajt.13413. Epub 2015 Aug 4.

13.

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O'Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC.

Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001. No abstract available. Erratum in: Am J Kidney Dis. 2015 Sep;66(3):545. Am J Kidney Dis. 2015 Sep;66(3):545.

14.

Historical Matching Strategies in Kidney Paired Donation: The 7-Year Evolution of a Web-Based Virtual Matching System.

Fumo DE, Kapoor V, Reece LJ, Stepkowski SM, Kopke JE, Rees SE, Smith C, Roth AE, Leichtman AB, Rees MA.

Am J Transplant. 2015 Oct;15(10):2646-54. doi: 10.1111/ajt.13337. Epub 2015 May 26.

15.

Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients.

Yamada C, Ramon DS, Cascalho M, Sung RS, Leichtman AB, Samaniego M, Davenport RD.

Transfusion. 2015 Apr;55(4):727-35; quiz 726. doi: 10.1111/trf.12923. Epub 2014 Nov 11.

16.

Decision Making in Kidney Paired Donation Programs with Altruistic Donors.

Li Y, Song PX, Leichtman AB, Rees MA, Kalbfleisch JD.

Sort (Barc). 2014 Jan;38(1):53-72.

17.

Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes.

Messersmith EE, Gross CR, Beil CA, Gillespie BW, Jacobs C, Taler SJ, Merion RM, Jowsey SG, Leichtman AB, Hong BA; RELIVE Study Group.

Transplantation. 2014 Dec 27;98(12):1294-300. doi: 10.1097/TP.0000000000000360.

18.

Patient selection and volume in the era surrounding implementation of Medicare conditions of participation for transplant programs.

White SL, Zinsser DM, Paul M, Levine GN, Shearon T, Ashby VB, Magee JC, Li Y, Leichtman AB.

Health Serv Res. 2015 Apr;50(2):330-50. doi: 10.1111/1475-6773.12188. Epub 2014 May 19.

19.

Optimal Decisions for Organ Exchanges in a Kidney Paired Donation Program.

Li Y, Song PX, Zhou Y, Leichtman AB, Rees MA, Kalbfleisch JD.

Stat Biosci. 2014 May 1;6(1):85-104.

20.

Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference.

Melcher ML, Blosser CD, Baxter-Lowe LA, Delmonico FL, Gentry SE, Leishman R, Knoll GA, Leffell MS, Leichtman AB, Mast DA, Nickerson PW, Reed EF, Rees MA, Rodrigue JR, Segev DL, Serur D, Tullius SG, Zavala EY, Feng S.

Am J Transplant. 2013 Apr;13(4):851-860. doi: 10.1111/ajt.12140. Epub 2013 Feb 7.

21.

Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades.

Taler SJ, Messersmith EE, Leichtman AB, Gillespie BW, Kew CE, Stegall MD, Merion RM, Matas AJ, Ibrahim HN; RELIVE Study Group.

Am J Transplant. 2013 Feb;13(2):390-8. doi: 10.1111/j.1600-6143.2012.04321.x. Epub 2012 Nov 8.

22.

Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilization.

White SL, Leichtman AB, O'Connor K, Lipkowitz G, Pietroski R, Stoff JS, Luskin RS, Belcher J, Meyer K, Merion RM, Port FK, Delmonico FL.

Transplant Proc. 2012 Sep;44(7):2223-6. doi: 10.1016/j.transproceed.2012.07.103.

PMID:
22974959
23.

Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors.

Woodside KJ, Merion RM, Leichtman AB, de los Santos R, Arrington CJ, Rao PS, Sung RS.

Am J Transplant. 2012 Aug;12(8):2106-14. doi: 10.1111/j.1600-6143.2012.04146.x. Epub 2012 Jun 15.

24.

Call to develop a standard acquisition charge model for kidney paired donation.

Rees MA, Schnitzler MA, Zavala EY, Cutler JA, Roth AE, Irwin FD, Crawford SW, Leichtman AB.

Am J Transplant. 2012 Jun;12(6):1392-7. doi: 10.1111/j.1600-6143.2012.04034.x. Epub 2012 Apr 9.

25.

Transplanting kidneys without points for HLA-B matching: consequences of the policy change.

Ashby VB, Port FK, Wolfe RA, Wynn JJ, Williams WW, Roberts JP, Leichtman AB.

Am J Transplant. 2011 Aug;11(8):1712-8. doi: 10.1111/j.1600-6143.2011.03606.x. Epub 2011 Jun 14.

26.

Improving the allocation system for deceased-donor kidneys.

Leichtman AB, McCullough KP, Wolfe RA.

N Engl J Med. 2011 Apr 7;364(14):1287-9. doi: 10.1056/NEJMp1102728. Epub 2011 Mar 16. No abstract available.

PMID:
21410390
27.

Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival.

Fan PY, Ashby VB, Fuller DS, Boulware LE, Kao A, Norman SP, Randall HB, Young C, Kalbfleisch JD, Leichtman AB.

Am J Transplant. 2010 Apr;10(4 Pt 2):1090-107. doi: 10.1111/j.1600-6143.2009.03009.x.

28.

Predictability of survival models for waiting list and transplant patients: calculating LYFT.

Wolfe RA, McCullough KP, Leichtman AB.

Am J Transplant. 2009 Jul;9(7):1523-7. doi: 10.1111/j.1600-6143.2009.02708.x.

29.

Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease.

McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB.

Am J Transplant. 2009 Apr;9(4 Pt 2):894-906. doi: 10.1111/j.1600-6143.2009.02566.x.

30.

Should pediatric patients wait for HLA-DR-matched renal transplants?

Gritsch HA, Veale JL, Leichtman AB, Guidinger MK, Magee JC, McDonald RA, Harmon WE, Delmonico FL, Ettenger RB, Cecka JM.

Am J Transplant. 2008 Oct;8(10):2056-61.

31.

Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates.

Wolfe RA, McCullough KP, Schaubel DE, Kalbfleisch JD, Murray S, Stegall MD, Leichtman AB.

Am J Transplant. 2008 Apr;8(4 Pt 2):997-1011. doi: 10.1111/j.1600-6143.2008.02177.x.

32.

Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge.

Leichtman AB, Cohen D, Keith D, O'Connor K, Goldstein M, McBride V, Gould CJ, Christensen LL, Ashby VB.

Am J Transplant. 2008 Apr;8(4 Pt 2):946-57. doi: 10.1111/j.1600-6143.2008.02173.x.

33.

Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion.

Sung RS, Christensen LL, Leichtman AB, Greenstein SM, Distant DA, Wynn JJ, Stegall MD, Delmonico FL, Port FK.

Am J Transplant. 2008 Apr;8(4):783-92. doi: 10.1111/j.1600-6143.2008.02157.x. Epub 2008 Feb 19.

34.

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference.

Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, Hays R, Howard A, Jones E, Leichtman AB, Merion RM, Metzger RA, Pradel F, Schweitzer EJ, Velez RL, Gaston RS.

Clin J Am Soc Nephrol. 2008 Mar;3(2):471-80. doi: 10.2215/CJN.05021107. Epub 2008 Feb 6.

35.

Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation.

Keith D, Ashby VB, Port FK, Leichtman AB.

Clin J Am Soc Nephrol. 2008 Mar;3(2):463-70. doi: 10.2215/CJN.02220507. Epub 2008 Jan 16.

36.

Balancing efficacy and toxicity in kidney-transplant immunosuppression.

Leichtman AB.

N Engl J Med. 2007 Dec 20;357(25):2625-7. No abstract available.

PMID:
18094383
37.

Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys.

Sung RS, Guidinger MK, Leichtman AB, Lake C, Metzger RA, Port FK, Merion RM.

Transplantation. 2007 Nov 15;84(9):1138-44.

PMID:
17998869
38.

Kidney vending: the "Trojan horse" of organ transplantation.

Danovitch GM, Leichtman AB.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1133-5. Epub 2006 Oct 4. No abstract available.

39.

The rationale for the new deceased donor pancreas allocation schema.

Stegall MD, Dean PG, Sung R, Guidinger MK, McBride MA, Sommers C, Basadonna G, Stock PG, Leichtman AB.

Transplantation. 2007 May 15;83(9):1156-61.

PMID:
17496529
40.

Repeat organ transplantation in the United States, 1996-2005.

Magee JC, Barr ML, Basadonna GP, Johnson MR, Mahadevan S, McBride MA, Schaubel DE, Leichtman AB.

Am J Transplant. 2007;7(5 Pt 2):1424-33.

41.

Geographic variability in access to primary kidney transplantation in the United States, 1996-2005.

Ashby VB, Kalbfleisch JD, Wolfe RA, Lin MJ, Port FK, Leichtman AB.

Am J Transplant. 2007;7(5 Pt 2):1412-23.

42.

Developing organ offer and acceptance measures: when 'good' organs are turned down.

Wolfe RA, LaPorte FB, Rodgers AM, Roys EC, Fant G, Leichtman AB.

Am J Transplant. 2007;7(5 Pt 2):1404-11.

43.

Development and current status of ECD kidney transplantation.

Sung RS, Guidinger MK, Christensen LL, Ashby VB, Merion RM, Leichtman AB, Port FK.

Clin Transpl. 2005:37-55.

PMID:
17424724
44.

Immunosuppression: evolution in practice and trends, 1994-2004.

Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, Barr ML, Leichtman AB.

Am J Transplant. 2006;6(5 Pt 2):1111-31.

45.

Mortality after kidney transplantation: a comparison between the United States and Canada.

Kim SJ, Schaubel DE, Fenton SS, Leichtman AB, Port FK.

Am J Transplant. 2006 Jan;6(1):109-14.

46.

Report of a National Conference on Donation after cardiac death.

Bernat JL, D'Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML, Marks WH, Nathan H, O'connor K, Rudow DL, Leichtman AB, Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner D, Warren J, Delmonico FL.

Am J Transplant. 2006 Feb;6(2):281-91.

47.

Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys.

Sung RS, Guidinger MK, Lake CD, McBride MA, Greenstein SM, Delmonico FL, Port FK, Merion RM, Leichtman AB.

Transplantation. 2005 May 15;79(9):1257-61.

PMID:
15880081
48.

Immunosuppression: evolution in practice and trends, 1993-2003.

Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB.

Am J Transplant. 2005 Apr;5(4 Pt 2):874-86.

49.

Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report.

Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J, Leichtman AB, Delmonico FL; National Kidney Foundation Task Force on Diabetes and Transplantation.

Am J Kidney Dis. 2004 Sep;44(3):529-42. Review.

PMID:
15332226
50.

Association of center volume with outcome after liver and kidney transplantation.

Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM.

Am J Transplant. 2004 Jun;4(6):920-7.

Supplemental Content

Loading ...
Support Center